Hepatitis A IgM (Anti-HAV IgM, HAVAb-IgM)
412
Information
This assay is intended for use as an aid in the diagnosis of acute or recent infection (usually 6 months or less) with hepatitis A virus (HAV). This is an in vitro diagnostic immunoassay for the qualitative determination of IgM response to HAV. The presence of IgM antibody to HAV is diagnostic of acute HAV infection. To reduce false-positive tests, persons should only be tested for IgM anti-HAV if they are symptomatic and suspected of having HAV infection.
Synonyms: Anti-HAV, IgM; Antibody to Hepatitis A Virus, IgM HAVAb, IgM, HAVAb-IgM
Methodology
Immunoassay (IA)
Specimen Required
SST, Serum. Volume 1 (0.5) mL. Volume 1 (0.5) mL. Stability: Room temperature – 14 days, Refrigerated – 14 days, Frozen – 30 days.
CPT Code(s)
86709